Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition.
- Author:
Jae Kwan LEE
1
;
Jin Hwa HONG
;
Sokbom KANG
;
Dae Yeon KIM
;
Byoung Gie KIM
;
Sung Hoon KIM
;
Yong Man KIM
;
Jae Weon KIM
;
Jae Hoon KIM
;
Tae Jin KIM
;
Hyun Jung KIM
;
Hye Sun KIM
;
Hee Sug RYU
;
Jae Yun SONG
;
Hyeong Sik AHN
;
Chong Woo YOO
;
Hye Kyoung YOON
;
Keun Ho LEE
;
Ahwon LEE
;
Yonghee LEE
;
In Ho LEE
;
Jeong Won LEE
;
Taek Sang LEE
;
Myong Cheol LIM
;
Suk Joon CHANG
;
Hyun Hoon CHUNG
;
Woong JU
;
Hee Jae JOO
;
Soo Young HUR
;
Sung Ran HONG
;
Joo Hyun NAM
Author Information
- Publication Type:Review
- Keywords: Atypical glandular cells; Atypical squamous cells; Cervical cancer; Human papillomavirus; Screening; Squamous intraepithelial lesion
- MeSH: Adolescent; Consensus; DNA; Female; Hospitals, University; Humans; Mass Screening; Pregnant Women; Societies; Uterine Cervical Neoplasms
- From:Journal of Gynecologic Oncology 2013;24(2):186-203
- CountryRepublic of Korea
- Language:English
- Abstract: The consensus guideline development committee of Korean Society of Gynecologic Oncology was reconvened in March 2012. The committee consisted of 36 experts representing 12 university hospitals and professional organizations. The objective of this committee was to develop standardized guidelines for cervical cancer screening tests for Korean women and to distribute these guidelines to every clinician, eventually improving the quality of medical care. Since the establishment of the consensus guideline development committee, evidence-based guidelines have either been developed de novo considering specific Korean situations or by adaptation of preexisting consensus guidelines from other countries. Recommendations for cervical cancer screening tests, management of atypical squamous and glandular cells, and management of low-grade and high-grade squamous intraepithelial lesions were developed. Additionally, recommendations for human papillomavirus DNA testing and recommendations for adolescent and pregnant women with abnormal cervical screening test results were also included.
